This site contains promotional information intended only for healthcare professionals resident in the United Kingdom
Menu
Close
Example of description text sitting alongside header
Example of description text sitting alongside header
Menu
Close
Example of description text sitting alongside header
Example of description text sitting alongside header
Menu
Close
Adverse event reporting can be found at the bottom of the page
Menu
Close
The content of this website has been produced in line with the IBRANCE® Summary of Product Characteristics for the UK. IBRANCE® (palbociclib) Prescribing Information for the UK click here. Adverse event reporting information can be found at the bottom of the page.
Pfizer Oncology recognise the increasing importance of Non Medical Prescribing clinicians (NMPs) in supporting the patient pathway for many oral systemic anti-cancer therapies (SACTs), particularly where patients are stable. NMP clinicians play a vital role in supporting the delivery of cancer services in the NHS.
Pfizer Oncology have commissioned the services of subject matter expert Professor Nicola Stoner, Consultant Pharmacist at Oxford University Hospitals NHS Foundation Trust to produce some NMP materials. The purpose of these materials is to support the development and future proofing of NMP services within Oncology. Their aim is to enhance service experience and improve outcomes for patients.
These resources include:
- NMP Summary guide
- NMP detailed guide
- NMP Business Case Template
This summary implementation guide aims to provide a concise step-by-step approach to implement NMP clinics within your Trust. Written by Prof Nicola Stoner
This detailed implementation guide provides a step-by-step approach to
introducing and maintaining non-medical prescriber (NMP) clinics within your Trust. This guide has been developed in collaboration with Professor Nicola Stoner
A business case template for NMP clinics, in a word document that is easy to customise for your trust.
Adverse events should be reported. Reporting forms and information can be found at https://yellowcard.mhra.gov.uk or search
for MHRA Yellow Card in Google Play or Apple App Store
Adverse events should also be reported to Pfizer Medical Information on 01304 616161
To access further materials, resources and receive communication about medicines and vaccines promoted by Pfizer.
This site is intended only for healthcare professionals resident in the United Kingdom. If you are a member of the public wishing to access information on a specific medicine, please visit www.medicines.org.uk/emc
This website is brought to you by Pfizer Limited, a company registered in England
and Wales under No. 526209 with its registered office at Ramsgate Road, Sandwich, Kent, CT13 9NJ
Copyright © 2025 Pfizer Limited. All rights reserved.
VAT registration number GB201048427
These pages are not intended for patients or for members of the general public. The healthcare professional web pages contain promotional content.
I confirm that I am a healthcare professional* resident in the United Kingdom.
If you select 'No', you will be redirected to Pfizer.co.uk where you will be able to access reference information on Pfizer's prescription medicines.
*The ABPI Code definition for healthcare professional is members of the medical, dental, pharmacy and nursing professionals and any other persons who in the course of their professional activities may administer, prescribe, purchase, recommend or supply a medicine.
PP-UNP-GBR-7812. January 2024.